USD 10.04
(-3.09%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 112.03 Million USD | 161.08% |
2022 | 42.91 Million USD | 462.46% |
2021 | 7.62 Million USD | 21.85% |
2020 | 6.26 Million USD | -69.0% |
2019 | 20.19 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 110.55 Million USD | 0.06% |
2024 Q1 | 110.48 Million USD | -1.38% |
2023 Q1 | 42.89 Million USD | -0.04% |
2023 FY | 112.03 Million USD | 161.08% |
2023 Q4 | 112.03 Million USD | 160.97% |
2023 Q3 | 42.92 Million USD | 0.04% |
2023 Q2 | 42.91 Million USD | 0.04% |
2022 Q3 | 43.22 Million USD | -0.11% |
2022 FY | 42.91 Million USD | 462.46% |
2022 Q2 | 43.27 Million USD | 0.06% |
2022 Q1 | 43.25 Million USD | 466.94% |
2022 Q4 | 42.91 Million USD | -0.73% |
2021 Q2 | 22.29 Million USD | 0.0% |
2021 FY | 7.62 Million USD | 21.85% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 7.62 Million USD | -67.57% |
2021 Q3 | 23.52 Million USD | 5.51% |
2020 FY | 6.26 Million USD | -69.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 6.26 Million USD | 0.0% |
2019 FY | 20.19 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 99.294% |
Allurion Technologies Inc. | 41.85 Million USD | -167.649% |
Artivion, Inc. | 359.34 Million USD | 68.823% |
Avanos Medical, Inc. | 209.1 Million USD | 46.423% |
Butterfly Network, Inc. | 25.02 Million USD | -347.637% |
Butterfly Network, Inc. | 25.02 Million USD | -347.637% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 92.031% |
Boston Scientific Corporation | 9.49 Billion USD | 98.82% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 88.698% |
Edwards Lifesciences Corporation | 694.9 Million USD | 83.878% |
Glaukos Corporation | 383.73 Million USD | 70.806% |
Globus Medical, Inc. | 520.4 Million USD | 78.472% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -350.898% |
Integer Holdings Corporation | 1.04 Billion USD | 89.238% |
Medtronic plc | 26.04 Billion USD | 99.57% |
Nevro Corp. | 221.82 Million USD | 49.497% |
Owlet, Inc. | 15.21 Million USD | -636.264% |
Penumbra, Inc. | 234.34 Million USD | 52.194% |
Vicarious Surgical Inc. | 14.83 Million USD | -655.326% |
Smith & Nephew plc | 3.08 Billion USD | 96.367% |
Sonendo, Inc. | 40.35 Million USD | -177.639% |
STERIS plc | 3.38 Billion USD | 96.689% |
Stryker Corporation | 12.99 Billion USD | 99.138% |
Vapotherm, Inc. | 112.39 Million USD | 0.322% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 98.131% |